Leading science, pioneering therapies
CRM Publications

Insulin-like growth factor-1 promotes wound healing in estrogen-deprived mice: new insights into cutaneous IGF-1R/ERα cross talk.

TitleInsulin-like growth factor-1 promotes wound healing in estrogen-deprived mice: new insights into cutaneous IGF-1R/ERα cross talk.
Publication TypeJournal Article
Year of Publication2012
AuthorsEmmerson E, Campbell L, Davies FCJ, Ross NL, Ashcroft GS, Krust A, Chambon P, Hardman MJ
JournalJ Invest Dermatol
Volume132
Issue12
Pagination2838-48
Date Published2012 Dec
ISSN1523-1747
KeywordsAnimals, Cells, Cultured, Dermatitis, Dermis, Disease Models, Animal, Estrogen Receptor alpha, Estrogens, Female, Fibroblasts, Humans, Insulin-Like Growth Factor I, Keratinocytes, Macrophages, Peritoneal, Mice, Mice, Inbred C57BL, Mice, Mutant Strains, Ovariectomy, Receptor Cross-Talk, Receptor, IGF Type 1, Signal Transduction, Wound Healing
Abstract

Although it is understood that endogenous IGF-1 is involved in the wound repair process, the effects of exogenous IGF-1 administration on wound repair remain largely unclear. In addition, the signaling links between IGF-1 receptor (IGF-1R) and estrogen receptors (ERs), which have been elucidated in other systems, have yet to be explored in the context of skin repair. In this study, we show that locally administered IGF-1 promotes wound repair in an estrogen-deprived animal model, the ovariectomized (Ovx) mouse, principally by dampening the local inflammatory response and promoting re-epithelialization. Using specific IGF-1R and ER antagonists in vivo, we reveal that IGF-1-mediated effects on re-epithelialization are directly mediated by IGF-1R. By contrast, the anti-inflammatory effects of IGF-1 are predominantly via the ERs, in particular ERα. Crucially, in ERα-null mice, IGF-1 fails to promote healing, and local inflammation is increased. Our findings illustrate the complex interactions between IGF-1 and estrogen in skin. The fact that IGF-1 may compensate for estrogen deficiency in wound repair, and potentially other contexts, is an important consideration for the treatment of postmenopausal pathology.

DOI10.1038/jid.2012.228
Alternate JournalJ. Invest. Dermatol.
PubMed ID22810305
Publication institute
CRM